Original paper

Investigation of niclosamide as a repurposing agent for skeletal muscle atrophy

Volume: 16, Issue: 5, Pages: e0252135 - e0252135
Published: May 26, 2021
Abstract
Skeletal muscle atrophy is a feature of aging (termed sarcopenia) and various diseases, such as cancer and kidney failure. Effective drug treatment options for muscle atrophy are lacking. The tapeworm medication, niclosamide is being assessed for repurposing to treat numerous diseases, including end-stage cancer metastasis and hepatic steatosis. In this study, we investigated the potential of niclosamide as a repurposing drug for muscle atrophy....
Paper Details
Title
Investigation of niclosamide as a repurposing agent for skeletal muscle atrophy
Published Date
May 26, 2021
Journal
Volume
16
Issue
5
Pages
e0252135 - e0252135
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.